Mobile

A Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study to Evaluate the Efficacy and Safety of E2007 (perampanel) Given as Adjunctive Therapy in Subjects with Refractory Partial Seiz...

Update Il y a 4 ans
Reference: EUCTR2007-006168-31

A Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study to Evaluate the Efficacy and Safety of E2007 (perampanel) Given as Adjunctive Therapy in Subjects with Refractory Partial Seizures

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

The primary objective is to evaluate the efficacy of 2 doses of perampanel (8 and 12 mg) in comparison to placebo given as an adjunctive therapy in subjects with refractory partial seizures.

Inclusion criteria

  • Epilepsy: refractory partial seizures with or without secondary generalisation

Links